ArticleJournal of clinical laboratory analysis2022

CYP2S1 rs338599 polymorphism confers reduced risk to anti-tuberculosis drug-induced liver injury and may be a novel marker for its risk prediction.

Liyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.